Health Investment Returns: Harnessing Health as...

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recen...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
Achieving International Drug Price Parity: Trump’s Mandate
NICE HealthTech Methods Update
Navigating Challenges for Small Countries to Access Innovative Medicines
Urgent Call to Action for EU Clinical Trials Strategy
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
Cecolin 9 HPV Vaccine: A Game Changer for Cervical Cancer Prevention in China
EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030